Good evening...
SEARCH
LATEST NEWS
RESEARCH

Directly or indirectly, cancer will touch everyone's lives. There is no greater or more worthwhile challenge than the ongoing battle to develop and improve anti-cancer treatments, for everyone's sake.

research publications


University of York

2004/5


YORKSHIRE CANCER RESEARCH P53 RESEARCH GROUP
Director of Unit: Professor J. Milner

Milner, J. (2004)
Death without stress-the stiletto approach against disease.
The Biochemist 26, 16-18.

Allison, S.J. and Milner, J. (2004)
Remodelling chromatin on a global scale: a novel protective function of p53.
Carcinogenesis 25, 1551-1557.

Jiang, M. and Milner, J. (2004)
Selective Silencing of Viral Gene E6 and E7 Expression in HPV-Positive Human Cervical Carcinoma Cells Using Small Interfering RNAs.
Methods in Molecular Biology 292, 401-420.

Jiang, M., Rubbi, C.P. and Milner, J. (2004)
Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis.
Oligonucleotides 14, 1-10.

Warnock, L. and Raines, S.A. (2004)
Restoration of Wild-Type Conformation to Full-Length and Truncated p53 Proteins.
Cancer Biology & Therapy 3, 634-637.


YCR CANCER RESEARCH UNIT
Director of Unit: Professor N J Maitland

Maitland, N.J., Stanbridge L., and Dussupt, V. (2004)
Targeting Gene Therapy For Prostate Cancer
Current pharmaceutical design 10: 531-555

Richardson, G.D., Robson, G.N., Lang, S.H., Neal, D.E., Maitland, N.J., Collins, A.T. (2004)
CD133, a novel marker for human prostatic epithelial stem cells
Journal of Cell Science 117: 3539-3545

Lipinski, K.S., Djeha, H.A., Gawn, J., Cliffe, S., Maitland, N.J., Palmer, D.H., Mountain, A., Irvine, A.S., Wrighton, C.J. (2004)
Optimization of a synthetic -catenin-dependent promoter for tumour-specific cancer gene therapy
Molecular Therapy 10, 150-161


Department of Chemistry
Head of Department: Professor P.H. Walton

Martina, S. L. X., Taylor, R. J. K. (2004)
New Solid Supported Phosphonate Reagents for the Synthesis of Z-a,b-Unsaturated Esters.
Tetrahedron Lett. 45, 3279-3282.